BioSpace News Archive

Iterative Scopes, a leading Artificial Intelligence in Gastroenterology provider, today unveiled a partnership with Eli Lilly and Company

Dr. Ravi Ramamoorthi and Dr. Gordon Wetzstein to advise development of Proprio’s advanced surgical navigation platform.

First Dedicated Ambulatory Surgery Center To Join Carrum’s Network, Premier Spine Provides Improved Patient Experience with the Promise of Better Outcomes

Natera, Inc., a pioneer and global leader in cell-free DNA testing, announced that Alexey Aleshin, MD, Natera’s Senior Medical Director of Oncology, will participate in a panel discussion at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference.

At City of Hope, Arthur Riggs, Ph.D., and colleagues first developed the technology to create synthetic human insulin, used today by hundreds of millions of people worldwide for diabetes.

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, announced that Mina Sooch, Chief Executive Officer will present a corporate overview at the 2021 BIO CEO & Investor Conference and participate in select one-on-one investor meetings from February 16 to 18, 2021.

Akorn Operating Company LLC (Akorn), a leading specialty pharmaceutical company, announced that it received approval of its Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug Administration (FDA) for Loteprednol Etabonate Ophthalmic Gel, 0.5%.

Genomind®, the leader in comprehensive genetics and digital mental health services, has announced the launch of GenMed✔ Pro™ – Smarter Precision Gene-Drug Interaction Software.

Rite Aid is proud to partner with the federal government as an inaugural participant in the Federal Retail Pharmacy Program.

Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), Connectyx announced today the addition of three industry veterans to the company’s management team.